PMID- 11996791 OWN - NLM STAT- MEDLINE DCOM- 20020515 LR - 20190816 IS - 0165-4608 (Print) IS - 0165-4608 (Linking) VI - 134 IP - 1 DP - 2002 Apr 1 TI - Significance of cytogenetic and fluorescence in situ hybridization analysis in evaluating antichronic myeloid leukemia efficacy of different immune effector cells. PG - 21-4 AB - We report on the antileukemia effect of interleukin 2 (IL2) on different immune cells from 22 patients with chronic myeloid leukemia (CML). Bone marrow cells from these patients were first cultured in modified long-term bone marrow culture medium for several days, then separately cultured with lymphokine activated killer cells (LAK), cytokine-induced killer cells (CIK), and dendritic cell cocultured CIK (DC-CIK) for another 1-2 days. They were then detected for presence of the Philadelphia chromosome (Ph) by cytogenetic analysis and fluorescence in situ hybridization (FISH). The percentage of Ph-chromosome-positive cells in the bone marrow mononuclear cells after culturing with CIK and DC-CIK was significantly lower than that after culturing with IL2 or LAK. Our results demonstrate that cytogenetics and FISH are useful techniques for the evaluation of the anti-CML effect of immune cells and that CIK or DC-CIK can be appropriate candidates for adoptive immune cell therapy in vivo or for leukemia cell purging ex vivo. FAU - Tong, Chun Rong AU - Tong CR AD - Cellular Therapy Center, Institute of Hematology, People's Hospital, Peking University, No. 11 South Street, Xi-Zhi-Men, 100044 Beijing, P. R. China. phcet@public3.bta.net.com FAU - Hong, Bo AU - Hong B FAU - Qiu, Jing Ying AU - Qiu JY FAU - Chen, Zhong AU - Chen Z FAU - Lu, Dao Pei AU - Lu DP LA - eng PT - Journal Article PL - United States TA - Cancer Genet Cytogenet JT - Cancer genetics and cytogenetics JID - 7909240 RN - 0 (Interleukin-2) SB - IM MH - Adult MH - Aged MH - Bone Marrow Cells/cytology/immunology/metabolism MH - Coculture Techniques MH - Cytogenetic Analysis MH - Dendritic Cells/cytology/drug effects/immunology MH - Female MH - Humans MH - In Situ Hybridization, Fluorescence MH - Interleukin-2/pharmacology MH - Killer Cells, Lymphokine-Activated/cytology/drug effects/immunology MH - Killer Cells, Natural/cytology/drug effects/*immunology MH - Leukemia, Myelogenous, Chronic, BCR-ABL Positive/*genetics/immunology/pathology MH - Male MH - Philadelphia Chromosome MH - Tumor Cells, Cultured EDAT- 2002/05/09 10:00 MHDA- 2002/05/16 10:01 CRDT- 2002/05/09 10:00 PHST- 2002/05/09 10:00 [pubmed] PHST- 2002/05/16 10:01 [medline] PHST- 2002/05/09 10:00 [entrez] AID - S0165460801005891 [pii] AID - 10.1016/s0165-4608(01)00589-1 [doi] PST - ppublish SO - Cancer Genet Cytogenet. 2002 Apr 1;134(1):21-4. doi: 10.1016/s0165-4608(01)00589-1.